World Health Organisation (WHO). Pertussis 202. 2021. [Available from: https://www.who.int/health-topics/pertussis#tab=tab_1]
World Health Organisation (WHO). WHO vaccine-preventable diseases: monitoring system. 2020 global summary. 2020.
Miller E. Overview of Recent Clinical Trials of Acellular Pertussis Vaccines. Biologicals. 1999;27(2):79–86.
Andrews N, Stowe J, Wise L, Miller E. Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom. Vaccine. 2010;28(44):7215–20.
Choi YH, Campbell H, Amirthalingam G, van Hoek AJ, Miller E. Investigating the pertussis resurgence in England and Wales, and options for future control. BMC medicine. 2016;14(1):121.
Amirthalingam G, Campbell H, Ribeiro S, Fry NK, Ramsay M, Miller E, et al. Sustained Effectiveness of the Maternal Pertussis Immunization Program in England 3 Years Following Introduction. Clinical Infectious Diseases. 2016;63(suppl_4):S236-S43.
Public Health England. Pertussis vaccination programme for pregnant women update: vaccine coverage in England, January to March 2021 and 2020 to 2021 annual coverage. 2021.
Joint Committee on Vaccination and Immunisation. Minute of the meeting held on 05 June 2019. 2019. [Available from: https://app.box.com/s/iddfb4ppwkmtjusir2tc]
Gov.uk. Prime Minister’s statement on coronavirus (COVID-19): 23 March 2020 2020 [Available from: https://www.gov.uk/government/speeches/pm-address-to-the-nation-on-coronavirus-23-march-2020]
Brueggemann AB, Jansen van Rensburg MJ, Shaw D, McCarthy ND, Jolley KA, Maiden MCJ, et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data. The Lancet Digital health. 2021;3(6):e360-e70.
Public Health England. Surveillance of influenza and other seasonal respiratory viruses in the UK Winter 2020 to 2021. 2021. [Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/995284/Surveillance_of_influenza_and_other_seasonal_respiratory_viruses_in_the_UK_2020_to_2021-1.pdf]
Amin-Chowdhury Z, Aiano F, Mensah A, Sheppard CL, Litt D, Fry NK, et al. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2021;72(5):e65-e75.
Subbarao S, Campbell H, Ribeiro S, Clark S, Lucidarme J, Ramsay M, et al. Invasive Meningococcal Disease, 2011–2020, and Impact of the COVID-19 Pandemic, England. Emerging Infect Dis J. 2021;27(9):2495–7.
Mehta OP, Bhandari P, Raut A, Kacimi SEO, Huy NT. Coronavirus Disease (COVID-19): Comprehensive Review of Clinical Presentation. 2021;8(1034):1–9.
Siebach MK, Piedimonte G, Ley SH. COVID-19 in childhood: Transmission, clinical presentation, complications and risk factors. 2021;56(6):1342–56.
Kretzschmar M, Teunis PFM, Pebody RG. Incidence and Reproduction Numbers of Pertussis: Estimates from Serological and Social Contact Data in Five European Countries. PLOS Medicine. 2010;7(6):e1000291.
Gov.uk. The official UK government website for data and insights on coronavirus (COVID-19). 2021 [Available from: https://coronavirus.data.gov.uk/]
Fry NK, Litt DJ, Duncan J, Vaghji L, Warrener L, Samuel D, et al. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay. Journal of medical microbiology. 2013;62(Pt 9):1281–9.
Public Health England. Laboratory confirmed cases of pertussis in England: annual report for 2020. 2021.
Public Health England. Complete routine immunisation schedule. 2020.
Public Health England. ImmForm 2021 [Available from: https://portal.immform.phe.gov.uk/Logon.aspx?returnurl=%2f]
Public Health England. Quarterly vaccination coverage statistics for children aged up to 5 years in the UK (COVER programme): January to March 2021. 2021.
Public Health England. Cover of vaccination evaluated rapidly programme 2021 [Available from: https://www.gov.uk/government/collections/vaccine-uptake#cover-of-vaccination-evaluated-rapidly-programme]
Matczak S, Levy C, Fortas C, Cohen JF, Béchet S, El Belghiti FA, et al. Association between the COVID-19 pandemic and pertussis in France using multiple nationwide data sources. medRxiv. 2021:2021.07.16.21260367.
Oh SC, Park SM, Hur J, Choi EY, Jin HJ, Kim YK, et al. Effectiveness of rapid multiplex polymerase chain reaction for early diagnosis and treatment of pertussis. J Microbiol Immunol Infect. 2021;54(4):687–92.
Public Health England. Quarterly vaccination coverage statistics for children aged up to five years in the UK (COVER programme): January to March 2020 2020 [Available from: https://www.gov.uk/government/statistics/cover-of-vaccination-evaluated-rapidly-cover-programme-2019-to-2020-quarterly-data]
Edmunds M, Mearkle R, Folliard J, Anderson C, Balasegaram S, Chandra N, et al. Retrospective cohort study investigating extent of pertussis transmission during a boarding school outbreak, England, December 2017 to June 2018. Euro Surveillance. 2021;26(26):1–9.
Tessier E, Campbell H, Ribeiro S, Andrews N, Stowe J, Nicholls M, et al. Investigation of a pertussis outbreak and comparison of two acellular booster pertussis vaccines in a junior school in South East England, 2019. 2021;26(12):2000244.
Williams TC, Sinha I, Barr IG, Zambon M. Transmission of paediatric respiratory syncytial virus and influenza in the wake of the COVID-19 pandemic. 2021;26(29):2100186.
Zhang R, Deng J. Clinical impact of respiratory syncytial virus infection on children hospitalized for pertussis. BMC Infect Dis. 2021;21(1):161.
Frassanito A, Nenna R, Nicolai A, Pierangeli A, Tozzi AE, Stefanelli P, et al. Infants hospitalized for Bordetella pertussis infection commonly have respiratory viral coinfections. BMC infectious diseases. 2017;17(1):492.
Crowcroft NS, Booy R, Harrison T, Spicer L, Britto J, Mok Q, et al. Severe and unrecognised: pertussis in UK infants. Archives of Disease in Childhood. 2003;88(9):802.
Amirthalingam G, Gupta S, Campbell H. Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review. Euro Surveillance. 2013;18(38):1–9.
Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014;384(9953):1521–8.
Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18(2):326–82.
Wendelboe AM, Njamkepo E, Bourillon A, Floret DD, Gaudelus J, Gerber M, et al. Transmission of Bordetella pertussis to Young Infants. Pediatric Infect Dis J. 2007;26(4):293–9.
gov.uk Biggest flu programme in history to roll out for winter 2021. 2021. [Available from: https://www.gov.uk/government/news/biggest-flu-programme-in-history-to-roll-out-for-winter-2021]
Public Health England. COVID-19: impact on vaccination programmes. 2021. [Available from: https://www.gov.uk/government/publications/covid-19-impact-on-vaccination-programmes]
Public Health England. HPV vaccination coverage in adolescent females and males in England: 2019 to 2020. 2020. [Available here: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/927694/hpr1920_HPV-vc.pdf]
Public Health England. Herpes zoster (shingles) immunisation programme 2020 to 2021: evaluation reports. 2021. [Available from: https://www.gov.uk/government/publications/herpes-zoster-shingles-immunisation-programme-2020-to-2021-evaluation-reports]